SM
ZBH icon

Scoggin Management’s Zimmer Biomet ZBH Stock Holding History

Scoggin Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,600
Closed -$2.35M – 121
2015
Q1 		$2.35M Buy
+20,600
New +$2.35M 0.19% 68

Other funds holding ZBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Scoggin Management's ZBH Position: Q2 2015 in Review

Scoggin Management sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 20,600 shares — an estimated $2.35M sold.

Scoggin Management first reported a position in ZBH in Q1 2015 and held it in 1 quarter. The position peaked at $2.35M in Q1 2015. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

  • Scoggin Management reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
  • Scoggin Management sold 20,600 Zimmer Biomet shares in Q2 2015, an estimated $2.35M.
  • Scoggin Management first reported a position in Zimmer Biomet in Q1 2015 and held it in 1 quarter.
  • Scoggin Management's Zimmer Biomet position peaked at $2.35M in Q1 2015.
  • 749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Scoggin Management's 13F filing for Q2 2015, filed 14 Aug 2015.